Skip to main content
Log in
Home
All Courses
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I
Summary
Course
Credit Activity Report
PARS log
More
Course info
Conferences and Meetings
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I
Category:
Conferences and Meetings
Short name:
updated-101. Red Cells and Erythropoiesis, Excluding Iron: Poster I- 2023
Course start date:
01/12/2026
Enroll me
Sections
General
0 activities
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I
0 activities
Classical Complement Inhibition By SAR445088 (BIVV020) in Adults with Cold Agglutinin Disease: Safety, Tolerability and Activity Results from the Open
1 activities
Classical Complement Inhibition By SAR445088 (BIVV020) in Adults with Cold Agglutinin Disease: Safety, Tolerability and Activity Results from the Open
Interconnections between DDX41-Dependent Post-Transcriptional and GATA Factor-Instigated Transcriptional Mechanisms That Govern Hematopoiesis
1 activities
Interconnections between DDX41-Dependent Post-Transcriptional and GATA Factor-Instigated Transcriptional Mechanisms That Govern Hematopoiesis
Multi-Omics Analysis of the Impact of Long Distance Trail Running on Red Blood Cells Highlights Acylcarnitine Mediated Lipid Damage Repair Mechanisms
1 activities
Multi-Omics Analysis of the Impact of Long Distance Trail Running on Red Blood Cells Highlights Acylcarnitine Mediated Lipid Damage Repair Mechanisms
Ncrna-a3 Epigenetically Regulates TAL1 and Its Target Genes to Drive Erythroid Differentiation
1 activities
Ncrna-a3 Epigenetically Regulates TAL1 and Its Target Genes to Drive Erythroid Differentiation
Caspase-1 As a Therapeutic Target in Intravascular Hemolysis-Induced Microvascular Inflammation and Occlusive Processes
1 activities
Caspase-1 As a Therapeutic Target in Intravascular Hemolysis-Induced Microvascular Inflammation and Occlusive Processes
Congenital Dyserythropoietic Anemia Type II: An Update from the Congenital Dyseryhtropoietic Anemia Registry of North America (CDAR)
1 activities
Congenital Dyserythropoietic Anemia Type II: An Update from the Congenital Dyseryhtropoietic Anemia Registry of North America (CDAR)
Early Response Transcription Factors in Erythroid Regeneration
1 activities
Early Response Transcription Factors in Erythroid Regeneration
Cell-Type Specific Requirement of Glucose Catabolism in Erythropoiesis and Thymopoiesis
1 activities
Cell-Type Specific Requirement of Glucose Catabolism in Erythropoiesis and Thymopoiesis
Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in F
1 activities
Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in F
Genome Wide siRNA Screen Identifies CGAS-Sting Pathway As a Pharmacological Target That Promotes Survival of Hematopoietic Stem Cells Deficient in Fan
1 activities
Genome Wide siRNA Screen Identifies CGAS-Sting Pathway As a Pharmacological Target That Promotes Survival of Hematopoietic Stem Cells Deficient in Fan
Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)
1 activities
Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)
A Phase I/II, Intra-Patient Dose-Escalation Study of Bitopertin, a Selective Inhibitor of GlyT1 and Heme Synthesis, for Steroid-Refractory Diamond-Bla
1 activities
A Phase I/II, Intra-Patient Dose-Escalation Study of Bitopertin, a Selective Inhibitor of GlyT1 and Heme Synthesis, for Steroid-Refractory Diamond-Bla
A Pilot Multicentric Prospective Study on the Usefulness of Peripheral Blood Immunophenotyping As Erythroid Maturation Response Marker during Luspate
1 activities
A Pilot Multicentric Prospective Study on the Usefulness of Peripheral Blood Immunophenotyping As Erythroid Maturation Response Marker during Luspate
Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Oxidative Stress and Promoted Terminal Erythropoiesis in a Severe Hem
1 activities
Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Oxidative Stress and Promoted Terminal Erythropoiesis in a Severe Hem
Novel RBC Adhesion and Deformability Assays Reveal Deleterious Effect of Diabetes on RBC Health
1 activities
Novel RBC Adhesion and Deformability Assays Reveal Deleterious Effect of Diabetes on RBC Health
Vimeo
15
Enroll me
Loading...
Help
Loading...
Accessibility
Text size
A-
A
A+
Color Adjustments
Monochrome
Low Saturation
High Saturation
High Contrast
Invert Colors
Change Hue
Reset Color Adjustments